Business, energy, technology, markets and global industry news from Business News Today
PharmaDeviceNews
A healthcare professional discusses HIV testing and treatment access as AIDS Healthcare Foundation and the Pan American Health Organization collaborate to tackle late diagnosis across Latin America and the Caribbean. Representative image.
Medical Devices & Diagnostics

Why the new AHF and PAHO HIV partnership faces a harder challenge than expanding testing

AHF and PAHO will expand early HIV testing and linkage to care as late diagnosis continues to drive preventable deaths across the region.

Read More
Waters brings StepWave XR robustness technology to clinical mass spectrometry
Medical Devices & Diagnostics

How Waters’ Xevo TQ Absolute XR could strengthen clinical LC-MS/MS workflows

Waters launches Xevo TQ Absolute XR IVD, promising higher sensitivity and robustness for estradiol, cancer assessment and toxicology workflows.

Read More
Pictor’s new PictImager targets faster, more practical multiplex protein analysis by combining 96-well assay imaging with automated biomarker data processing for research laboratories. Representative image.
Medical Devices & Diagnostics

Can Pictor’s new PictImager make multiplex proteomics practical beyond specialist laboratories?

Pictor launches its new PictImager at ADLM 2026, targeting faster, lower-cost multiplex protein analysis as beta-site testing begins.

Read More
A clinician discusses gastroesophageal cancer diagnosis, biomarker testing, treatment options and clinical trials with patients and caregivers ahead of the Debbie’s Dream Foundation and Yale Cancer Center community symposium. Representative image.
Pharma & Biotech

Debbie’s Dream Foundation expands patient education through Yale Cancer Center collaboration

Yale and Debbie’s Dream Foundation will explain diagnosis, biomarkers, treatment, trials and supportive care at a free cancer symposium.

Read More
Europe’s first Picasso Plus system begins clinical use at Sweden’s Falu Hospital
Medical Devices & Diagnostics

Why Falu Hospital selected KUBTEC Picasso Plus for breast specimen radiography

See how KUBTEC’s Picasso Plus installation at Falu Hospital could shape specimen radiography adoption across European pathology labs.

Read More
Rejuva Fresh brings PicoPretty laser to Canada as clinics weigh versatility against cost
Medical Devices & Diagnostics

PicoPretty laser receives Health Canada licence for Canadian aesthetic clinic market

Rejuva Fresh secures Health Canada licence 115678 for PicoPretty, opening Canadian sales while clinics assess evidence, training and ROI.

Read More
Feinstein Institutes releases comprehensive human vagus nerve map to advance precision neuromodulation
Medical Devices & Diagnostics

How the Feinstein Institutes vagus nerve map may advance bioelectronic medicine

Feinstein Institutes releases a detailed human vagus nerve map that could sharpen neuromodulation design, but clinical validation remains essential.

Read More
LAPIX Therapeutics strengthens its strategic leadership by appointing Nimbus Therapeutics Chief Executive Officer Abbas Kazimi to its board as investigational autoimmune drug LPX-TI641 advances through Phase 1b development. Representative image.
Pharma & Biotech

LAPIX Therapeutics adds biotech dealmaking expertise as LPX-TI641 studies progress

LAPIX adds Nimbus CEO Abbas Kazimi to its board as LPX-TI641 advances in Phase 1b autoimmune trials and prepares for Phase 2 decisions.

Read More
Advita Ortho’s acquisition of Bauer Innovations patent applications could support the development of new glenoid baseplates for complex revision shoulder arthroplasty involving severe bone loss. Representative image.
Medical Devices & Diagnostics

Advita Ortho expands Equinoxe Shoulder System through Bauer Innovations patent deal

Advita Ortho acquires Bauer Innovations patents to pursue off-the-shelf glenoid baseplates for complex reverse shoulder revision surgery.

Read More
Rising GLP-1 drug spending, hospital inflation, artificial intelligence-assisted medical coding and surprise billing arbitration are expected to push employer health plan costs toward a 15-year high in 2027. Representative image.
Pharma & Biotech

What Segal’s 2027 healthcare cost forecast means for employers, payers and PBMs

Segal projects a 9.9% medical plan cost trend for 2027 as GLP-1 drugs, AI coding and arbitration intensify employer cost pressure.

Read More